Anavex Life Sciences (AVXL) Notes Payables (2011 - 2015)
Anavex Life Sciences (AVXL) reported Notes Payables of $92516.0 for Q2 2015, down 53.93% on a YoY basis from $200835.0 in Q2 2014, and up 2.33% sequentially from $90412.0 in Q1 2015.
Anavex Life Sciences (AVXL) Notes Payables (2011 - 2015) Analysis & Trends
Anavex Life Sciences (AVXL) has 5 years of Notes Payables data on file, last reported at $92516.0 in Q2 2015.
- For the quarter ending Q2 2015, Notes Payables fell 53.93% year-over-year to $92516.0; the trailing twelve-month figure through Jun 2015 stood at $92516.0 (down 53.93% YoY), and the FY2014 full-year result was $192065.0, down 8.91% from the prior year.
- Notes Payables advanced to $92516.0 in Q2 2015, from $90412.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $867919.0 in Q3 2011 to a low of $90412.0 in Q1 2015.
- A 5-year average of $351069.1 and a median of $200835.0 in 2014 frame the typical range for Notes Payables.
- Peak annual rise in Notes Payables reached 8.91% in 2014, while the deepest fall reached 74.55% in 2014.
- Tracing AVXL's Notes Payables over 5 years: stood at $867919.0 in 2011, then tumbled by 30.98% to $599000.0 in 2012, then slumped by 66.55% to $200364.0 in 2013, then slumped by 50.93% to $98312.0 in 2014, then fell by 5.9% to $92516.0 in 2015.
- Business Quant data shows AVXL's Notes Payables at $92516.0 in Q2 2015, $90412.0 in Q1 2015, and $98312.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Anavex Life Sciences | 229.83 Mn | 98.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 92,516.00 |
| Mar 31, 2015 | 90,412.00 |
| Dec 31, 2014 | 98,312.00 |
| Sep 30, 2014 | 192,065.00 |
| Jun 30, 2014 | 200,835.00 |
| Mar 31, 2014 | 193,720.00 |
| Dec 31, 2013 | 200,364.00 |
| Sep 30, 2013 | 210,863.00 |
| Jun 30, 2013 | 757,600.00 |
| Mar 31, 2013 | 761,292.00 |
| Dec 31, 2012 | 599,000.00 |
| Sep 30, 2012 | 299,000.00 |
| Sep 30, 2011 | 867,919.00 |